OdysseaBio
De-risking communication from discovery to delivery for biotech, pharma, advocacy, and health decision-makers.
We partner with leadership teams to transform complex science into clear, compelling narratives that reduce risk, build trust, and drive confident decisions at every milestone.
The Challenge
Breakthrough science often stalls because communication fails to align.
Researchers, investors, advocacy groups, and health decision-makers speak different languages.
But when those voices are integrated, opportunities accelerate, funding flows, and milestones are achieved.
Our Approach
At OdysseaBio, we bridge science, business, and healthcare. We craft narratives that are scientifically rigorous, strategically clear, and credible to the audiences who matter most.
More than translation, we deliver transformation. Grounded in evidence and strategy, we help leaders move beyond empty shell narratives, achieve alignment, and build lasting trust.
De-Risking at Every Stage
At every stage of your product journey, we ensure your innovation is understood, trusted, and positioned for maximum impact.
-
Articulate the promise of your science to investors and partners with clarity and credibility from the start.
-
Align stakeholders, engage advocacy groups, and advance trial milestones with confidence.
-
Shape value messaging and positioning that minimize market-entry risk and resonate with payers, providers, and policymakers.
-
Sustain trust with clinicians, patients, advocacy groups, and decision-makers while evolving your story as new evidence emerges.
“We shape every message to accelerate decisions, minimize risk, and maximize the return on your innovation”
The OdysseaBio Co-Founders
Drawing on 40+ years of combined experience—from the lab bench to the strategic frontline—we shape narratives that reduce risk, build trust, and drive confident decisions across the product lifecycle.
As scientists who recognized the power of communication, we now work directly with leadership teams to ensure that breakthrough science is transformed into narratives that resonate with investors, advocacy groups, health decision-makers, and clinical stakeholders.
The name OdysseaBio reflects the long, complex journey of drug development. We serve as strategic partners along the way—bringing clarity, alignment, and evidence-based storytelling that advance innovation from discovery to delivery.
Deborah Maret, PhD
Research background in glioblastoma with deep insight into preclinical-to-clinical development
Expertise in medical affairs and commercialization, translating complex data (including RWD/RWE) into actionable insights for HCPs and patient groups
Developed preclinical study reports and strategic narratives for biotech startups
Directed strategic education initiatives, crafting evidence-based materials, manuscripts, and congress content for diverse clinical audiences
Georghia Michael, PhD
Research background in preclinical models of arrhythmia and heart failure
Extensive market access and reimbursement experience delivering value stories, global value dossiers, and HTA submissions
Transformed advisory board insights into strategy that informed medical affairs strategies
Aligned scientific communication with clinical and commercial objectives, drawing from insights at international scientific conferences
Our Values
Scientific Integrity
We uphold the highest standards of accuracy and ethics in communication.
Clarity & Impact
We turn complex science into messages that resonate and drive decisions.
Collaboration & Trust
We partner directly with teams to build alignment and confidence.
Patient-Centered Perspective
We place patients at the heart of every narrative.
Strategic Focus
We balance insight, precision, and adaptability to advance innovation.